LaBrosse Nicole

CIK 00019106621 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001910662

Recent Transactions

50 trades

Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23+6,688→ 42,102 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-23−6,688→ 36,357 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-23$70.64/sh−3,608→ 38,494 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-20−5,332→ 15,995 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20+5,332→ 38,290 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-20$70.98/sh−2,876→ 35,414 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−2,874→ 26,880 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+5,329→ 29,754 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-16−5,093→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-16−13,351→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−7,273→ 32,958 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2026-02-16−5,329→ 5,329 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+13,351→ 40,231 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16$79.44/sh−2,747→ 24,425 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2026-02-16+5,093→ 27,172 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+29,502→ 29,502 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+7,448→ 43,045 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2026-02-09+5,167→ 13,351 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-22$77.83/sh−1,913→ 22,393 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-22$78.67/sh−314→ 22,079 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$12.07/sh+11,271→ 43,171 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$75.93/sh−13,240→ 24,306 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-10−1,135→ 812 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-09-10−11,271→ 0 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$75.29/sh−6,760→ 37,546 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-09-10$12.49/sh+1,135→ 44,306 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-23−6,688→ 20,063 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23$57.75/sh−3,601→ 31,900 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-23+6,688→ 35,501 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-20+21,327→ 21,327 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Option to Purchase Common Stock
2025-02-20+22,603→ 22,603 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+17,409→ 33,402 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−9,400→ 24,002 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+5,329→ 31,682 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,869→ 28,813 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−5,093→ 5,093 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16$58.29/sh−2,742→ 26,353 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-16−5,329→ 10,658 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-16+5,093→ 29,095 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-16−17,409→ 0 total
Tax Payment
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15$58.29/sh−741→ 15,993 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Restricted Stock Units
2025-02-15−1,254→ 0 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2025-02-15+1,254→ 16,734 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+28,662→ 28,662 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Unit
2025-02-12+6,935→ 6,935 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+6,050→ 17,409 total
Award
HALOZYME THERAPEUTICS, INC.$HALO
Performance Stock Units
2025-02-12+5,221→ 8,184 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$54.25/sh−992→ 15,480 total
Exercise/Conversion
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$22.50/sh+992→ 16,472 total
Sale
HALOZYME THERAPEUTICS, INC.$HALO
Common Stock
2024-07-22$53.85/sh−4,008→ 15,480 total

Companies

HALOZYME THERAPEUTICS, INC.
SVP, CHIEF FINANCIAL OFFICER
$HALO

Recent Filings

Address

C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL

SAN DIEGO, CA, 92130

View on SEC.gov